Clinical Trial

A Multicenter Randomized Open-label Study of Diammonium Glycyrrhizinate Enteric-coated Capsule Plus DXM Versus DXM in Treatment of ITP

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The project was undertaking by Qilu Hospital of Shandong University in China. In order to report the efficacy and safety of diammonium glycyrrhizinate enteric-coated capsule plus high-dose dexamethasone for the treatment of adults with newly-diagnosed primary immune thrombocytopenia (ITP).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2021-08-21.
Status change: Recruiting → Active, Not Recruiting 2026-01-23
Trial Details
NCT Number NCT05023915
Lead Sponsor Shandong University
Conditions Immune Thrombocytopenia
Enrollment 106 participants
Start Date 2021-08-21
Primary Completion 2021-08-21 (estimated)
Study Completion 2026-01-31 (estimated)
Updated on ClinicalTrials.gov 2026-01-26